Mallinckrodt - M&A Summary and Business Overview

Life ScienceCompany

Mallinckrodt M&A Summary

Mallinckrodt has acquired 15 companies, including 1 in the last 5 years. A total of 6 acquisitions came from private equity firms. It has also divested 6 assets.

Mallinckrodt’s largest acquisition to date was in 2014, when it acquired Questcor Pharmaceuticals for $5.8B. It’s largest disclosed sale occurred in 2016, when it sold Mallinckrodt - Nuclear Imaging Business to IBA Molecular Imaging for $690M. Mallinckrodt has acquired in 8 different US states, and 2 countries. The Company’s most targeted sectors include life science (75%) and medical products (25%).

Mallinckrodt Business Overview

Where is Mallinckrodt headquartered?

Mallinckrodt is headquartered in Dublin, United Kingdom.

What is Mallinckrodt’s revenue?

Mallinckrodt disclosed revenue of 2,208M USD for 2021 and 2,213M USD for 2020.

How many employees does Mallinckrodt have?

Mallinckrodt has 2,673 employees.

What sector is Mallinckrodt in?

Mallinckrodt is a life science company.

When was Mallinckrodt founded?

Mallinckrodt was founded in 1867.

M&A Summary

  • M&A Total Activity18
    • M&A Buy Activity12
    • M&A Sell Activity6
  • Total Sectors Invested 2
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 13
  • M&A Advisors 5

Mallinckrodt

Mallinckrodt plc

College Business & Technology Park Cruiserath Blanchardstown,
Dublin, TW18 3AG
United Kingdom,
+353 1 696 0000
www.mallinckrodt.com

Mallinckrodt is a specialty pharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The company’s core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. Mallinckrodt was founded in 1867 and is based in Dublin, Ireland.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 12 - - - - - 12
vol $12.3B $12.3B
Sell (0.2/yr) # 5 - 1 - - - 6
vol $1.1B $1.1B
  18

Most Recent M&A

Company Date Value Type
Mallinckrodt plc - Adrabetadex 2021-05-19 - Divestiture
Dublin, Ireland
Silence Therapeutics Plc 2019-07-18 - Stake Purchase
London, United Kingdom · www.silence-therapeutics.com
Mallinckrodt plc - Recothrom and Preveleak 2018-03-19 - Divestiture
Dublin, Ireland
Sucampo Pharmaceuticals, Inc. 2017-12-26 1.2B USD Add-on Acquisition
Bethesda, Maryland · www.sucampo.com
Ocera Therapeutics, Inc. 2017-11-02 42M USD Add-on Acquisition
Palo Alto, California · www.ocerainc.com
InfaCare Pharmaceutical Corp. 2017-08-04 - Add-on Acquisition
Trevose, Pennsylvania · www.infacare.com
Mallinckrodt plc - Intrathecal Therapy Business 2017-01-30 171M USD Divestiture
Dublin, Ireland
Mallinckrodt - Nuclear Imaging Business 2016-08-24 690M USD Divestiture
Dublin, Ireland
Stratatech Corp. 2016-08-10 - Add-on Acquisition
Madison, Wisconsin · www.stratatechcorp.com
Medicines Company - Hemostasis Products 2015-12-18 175M USD Divestiture
, United States
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Questcor Pharmaceuticals, Inc. 2014-08-14 BioVectra, Inc. 2019-09-10 1
Anaheim, California · www.questcor.com Charlottetown, Prince Edward Island · www.biovectra.com

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 9 (75%) 9.6B (78%) 2 (33%) 171M (15%)
Medical Products 3 (25%) 2.7B (22%) 3 (50%) 960M (85%)
Healthcare Services - - 1 (17%) -
Total 12 $12.3B 6 $1.1B

By Geo

State/Country Buy Value Sell Value
United States 11 12.3B 1 270M
  California 3 7.1B - -
  Pennsylvania 2 1.3B - -
  Wisconsin 1 - - -
  Ohio 1 75M - -
  New Jersey 1 2.3B - -
  Minnesota 1 100M - -
  Maryland 1 1.2B - -
Ireland - - 4 861M
Sweden - - 1 -
United Kingdom 1 - - -
Domestic 1 (8%) - - -
Cross-border 11 (92%) 12.3B (100%) 6 (100%) 1.1B (100%)
Total 12 $12.3B 6 $1.1B

Top M&A Advisors

Financial Deals
Deutsche Bank Corporate & Investment Banking
2
Goldman Sachs
1
Barclays Investment Bank
1
Legal Deals
Wachtell, Lipton, Rosen & Katz
4
Arthur Cox & Co.
2

Deal Values

buy # Total
> $1B 5 $11.9B
$100M to $1B 1 $175M
< $100M 3 $217M
TOTAL $12.3B
Largest Questcor Pharmaceuticals, Inc.
$5.8B (2014-08-14)
sell # Total
$100M to $1B 3 $1.1B
TOTAL $1.1B
Largest Mallinckrodt - Nuclear Imaging Business
$690M (2016-08-24)

M&A Connections

Deals
Acquired from
Investor(s)
25%
3 (25%)
Strategic(s)
8%
1 (8%)
Divested to
Investor(s)
17%
1 (17%)
Strategic(s)
83%
5 (83%)

 Subscribe to unlock this and 201,688
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Mallinckrodt

Life Science Companies , United Kingdom Companies